These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 37501411)
1. Projections of human papillomavirus vaccination and its impact on cervical cancer using the Caputo fractional derivative. Simelane SM; Munyakazi JB; Dlamini PG; Egbelowo OF Math Biosci Eng; 2023 May; 20(7):11605-11626. PubMed ID: 37501411 [TBL] [Abstract][Full Text] [Related]
2. Modeling the impact of public health education on tungiasis dynamics with saturated treatment: Insight through the Caputo fractional derivative. Simelane SM; Dlamini PG; Osaye FJ; Obaido G; Ogbukiri B; Aruleba K; Jones CM; Chukwu CW; Egbelowo OF Math Biosci Eng; 2023 Feb; 20(5):7696-7720. PubMed ID: 37161168 [TBL] [Abstract][Full Text] [Related]
3. Global dynamics of a fractional order model for the transmission of HIV epidemic with optimal control. Naik PA; Zu J; Owolabi KM Chaos Solitons Fractals; 2020 Sep; 138():109826. PubMed ID: 32572309 [TBL] [Abstract][Full Text] [Related]
4. Modeling and analysis of COVID-19 epidemics with treatment in fractional derivatives using real data from Pakistan. Naik PA; Yavuz M; Qureshi S; Zu J; Townley S Eur Phys J Plus; 2020; 135(10):795. PubMed ID: 33145145 [TBL] [Abstract][Full Text] [Related]
5. Estimation of the potential overall impact of human papillomavirus vaccination on cervical cancer cases and deaths. Van Kriekinge G; Castellsagué X; Cibula D; Demarteau N Vaccine; 2014 Feb; 32(6):733-9. PubMed ID: 24291200 [TBL] [Abstract][Full Text] [Related]
6. Cervical cancer in Ethiopia: a review of the literature. Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682 [TBL] [Abstract][Full Text] [Related]
7. Facilitators and barriers of human papillomavirus vaccine uptake in young females 18-26 years old in Singapore: A qualitative study. Lim ASE; Lim RBT Vaccine; 2019 Sep; 37(41):6030-6038. PubMed ID: 31473002 [TBL] [Abstract][Full Text] [Related]
8. Memory impacts in hepatitis C: A global analysis of a fractional-order model with an effective treatment. Naik PA; Yavuz M; Qureshi S; Naik MU; Owolabi KM; Soomro A; Ganie AH Comput Methods Programs Biomed; 2024 Sep; 254():108306. PubMed ID: 38968828 [TBL] [Abstract][Full Text] [Related]
9. Mathematical assessment of monkeypox disease with the impact of vaccination using a fractional epidemiological modeling approach. Liu B; Farid S; Ullah S; Altanji M; Nawaz R; Wondimagegnhu Teklu S Sci Rep; 2023 Aug; 13(1):13550. PubMed ID: 37599330 [TBL] [Abstract][Full Text] [Related]
10. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium. Demarteau N; Van Kriekinge G; Simon P Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952 [TBL] [Abstract][Full Text] [Related]
11. Modelling the impact of vaccination and environmental transmission on the dynamics of monkeypox virus under Caputo operator. Addai E; Ngungu M; Omoloye MA; Marinda E Math Biosci Eng; 2023 Mar; 20(6):10174-10199. PubMed ID: 37322928 [TBL] [Abstract][Full Text] [Related]
12. Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis. Choi HCW; Jit M; Leung GM; Tsui KL; Wu JT BMC Med; 2018 Aug; 16(1):127. PubMed ID: 30115065 [TBL] [Abstract][Full Text] [Related]
13. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis. Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682 [TBL] [Abstract][Full Text] [Related]
14. Dynamics of high-risk nonvaccine human papillomavirus types after actual vaccination scheme. Peralta R; Vargas-De-León C; Cabrera A; Miramontes P Comput Math Methods Med; 2014; 2014():542923. PubMed ID: 24803952 [TBL] [Abstract][Full Text] [Related]
15. [Expert consensus on immunological prevention of human papillomavirus-related diseases]. Vaccine and Immunization Branch, Chinese Preventive Medicine Association Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Aug; 53(8):761-803. PubMed ID: 31378039 [TBL] [Abstract][Full Text] [Related]
16. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141 [TBL] [Abstract][Full Text] [Related]
17. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland. Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057 [TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus Vaccine: The Cancer Prevention Moonshot. Petrie K; Wells A; Eckert LO Obstet Gynecol Clin North Am; 2023 Jun; 50(2):339-348. PubMed ID: 37149314 [TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccination in the prevention of cervical neoplasia. Astbury K; Turner MJ Int J Gynecol Cancer; 2009 Dec; 19(9):1610-3. PubMed ID: 19955947 [TBL] [Abstract][Full Text] [Related]
20. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model. Gomez JA; Lepetic A; Demarteau N BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]